Discover 1,438 paid clinical trials in Bradenton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,438
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
Location: St. Petersburg FL, Miami FL, Gainesville FL,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 5 - 17
Code: NCT06229210
Phase3, Recruiting
Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients
for
Irritability Associated With Autism Spectrum Disorder
Location: St. Petersburg FL, Orlando FL, Pompano Beach FL,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 5 - 17
Code: NCT06706674
Phase3, Recruiting
Treatment of Anxiety in Late Adolescents With Autism
for
Autism Spectrum Disorder
Location: Saint Petersburg FL
Sponsor: University of South Florida
Sex: All
Age: 16 - 21
Code: NCT02977962
Recruiting
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Location: St. Petersburg FL, Gainesville FL, Miami FL,
Sponsor: University of Michigan
Sex: All
Age: 0 - 17
Code: NCT05376267
Recruiting
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
for
Hemoglobinopathy (Disorder), Severe Aplastic Anemia,
Location: St. Petersburg FL
Sponsor: Johns Hopkins All Children's Hospital
Sex: All
Age: 0 - 21
Code: NCT04356469
Phase2, Recruiting
Digoxin Medulloblastoma Study
for
Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH
Location: St. Petersburg FL, Tampa FL, Miami FL, Birmingham AL,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 1 - 30
Code: NCT06701812
Phase2, Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue